Literature DB >> 21242173

Impact and costs of targeted recruitment of minorities to the National Lung Screening Trial.

Catherine Duda1, Irene Mahon, Mei Hsiu Chen, Bradley Snyder, Richard Barr, Caroline Chiles, Robert Falk, Elliot K Fishman, David Gemmel, Jonathan G Goldin, Kathleen Brown, Reginald F Munden, Kay Vydareny, Denise R Aberle.   

Abstract

BACKGROUND: To promote results in the National Lung Screening Trial (NLST) that are generalizable across the entire US population, a subset of NLST sites developed dedicated strategies for minority recruitment.
PURPOSE: To report the effects of targeted strategies on the accrual of underrepresented groups, to describe participant characteristics, and to estimate the costs of targeted enrollment.
METHODS: The 2002-2004 Tobacco Use Supplement was used to estimate eligible proportions of racial and ethnic categories. Strategic planning included meetings/conferences with key stakeholders and minority organizations. Potential institutions were selected based upon regional racial/ethnic diversity and proven success in recruitment of underrepresented groups. Seven institutions submitted targeted recruitment strategies with budgets. Accrual by racial/ethnic category was tracked for each institution. Cost estimates were based on itemized receipts for minority strategies relative to minority accrual.
RESULTS: Of 18,842 participants enrolled, 1576 (8.4%) were minority participants. The seven institutions with targeted recruitment strategies accounted for 1223 (77.6%) of all minority participants enrolled. While there was a significant increase in the rate of minority accrual pre-implementation to post-implementation for the institutions with targeted recruitment (9.3% vs. 15.2%, p <  0.0001), there was no significant difference for the institutions without (3.5% vs. 3.8%, p = 0.46). Minority enrollees at the seven institutions tended to have less than a high school education, be economically disadvantaged, and were more often uninsured. These socio-demographic differences persisted at the seven institutions even after adjusting for race and ethnicity. The success of different strategies varied by institution, and no one strategy was successful across all institutions. Costs for implementation were also highly variable, ranging from $146 to $749 per minority enrollee. LIMITATIONS: Data on minority recruitment processes were not consistently kept at the individual institutions. In addition, participant responses via newspaper advertisements and the efforts of minority staff hired by the institutions could not be coded on Case Report Forms.
CONCLUSIONS: Strategic efforts were associated with significant increases in minority enrollment. The greatest successes require that a priori goals be established based on eligible racial/ethnic proportions; the historical performance of sites in minority accrual should factor into the selection of sites; recruitment planning must begin well in advance of trial launch; and there must be endorsement by prominent representatives of the racial groups of interest.

Entities:  

Mesh:

Year:  2011        PMID: 21242173      PMCID: PMC3258518          DOI: 10.1177/1740774510396742

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  8 in total

Review 1.  Knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials.

Authors:  J G Ford; M W Howerton; S Bolen; T L Gary; G Y Lai; J Tilburt; M C Gibbons; C Baffi; R F Wilson; C J Feuerstein; P Tanpitukpongse; N R Powe; E B Bass
Journal:  Evid Rep Technol Assess (Summ)       Date:  2005-06

Review 2.  Reducing cancer disparities for minorities: a multidisciplinary research agenda to improve patient access to health systems, clinical trials, and effective cancer therapy.

Authors:  Deborah Watkins Bruner; Michele Jones; David Buchanan; Jose Russo
Journal:  J Clin Oncol       Date:  2006-05-10       Impact factor: 44.544

Review 3.  Effective recruitment and retention of minority research participants.

Authors:  Antronette K Yancey; Alexander N Ortega; Shiriki K Kumanyika
Journal:  Annu Rev Public Health       Date:  2006       Impact factor: 21.981

Review 4.  Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review.

Authors:  Jean G Ford; Mollie W Howerton; Gabriel Y Lai; Tiffany L Gary; Shari Bolen; M Chris Gibbons; Jon Tilburt; Charles Baffi; Teerath Peter Tanpitukpongse; Renee F Wilson; Neil R Powe; Eric B Bass
Journal:  Cancer       Date:  2008-01-15       Impact factor: 6.860

5.  Minority recruitment to the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Authors:  Elise D Cook; Sarah Moody-Thomas; Karen B Anderson; Russell Campbell; Sandra J Hamilton; Joseph M Harrington; Scott M Lippman; Lori M Minasian; Electra D Paskett; Stephen Craine; Kathryn B Arnold; Jeffrey L Probstfield
Journal:  Clin Trials       Date:  2005       Impact factor: 2.486

6.  Participation in cancer clinical trials: race-, sex-, and age-based disparities.

Authors:  Vivek H Murthy; Harlan M Krumholz; Cary P Gross
Journal:  JAMA       Date:  2004-06-09       Impact factor: 56.272

7.  Recruitment of minority and underserved populations in the United States: the Centers for Population Health and Health Disparities experience.

Authors:  Electra D Paskett; Katherine W Reeves; John M McLaughlin; Mira L Katz; Ann Scheck McAlearney; Mack T Ruffin; Chanita Hughes Halbert; Cristina Merete; Faith Davis; Sarah Gehlert
Journal:  Contemp Clin Trials       Date:  2008-07-31       Impact factor: 2.226

8.  Recruitment methods employed in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Authors:  Lisa Gren; Karen Broski; Jeffery Childs; Jill Cordes; Deborah Engelhard; Betsy Gahagan; Eduard Gamito; Vivien Gardner; Mindy Geisser; Darlene Higgins; Victoria Jenkins; Lois Lamerato; Karen Lappe; Heidi Lowery; Colleen McGuire; Mollie Miedzinski; Sheryl Ogden; Sally Tenorio; Gavin Watt; Bonita Wohlers; Pamela Marcus
Journal:  Clin Trials       Date:  2009-02       Impact factor: 2.486

  8 in total
  15 in total

1.  Examining Gender Differences in Lung Cancer Screening.

Authors:  Simran Randhawa; Shelby R Sferra; Chandra Das; Larry R Kaiser; Grace X Ma; Cherie P Erkmen
Journal:  J Community Health       Date:  2020-10

2.  Retaining traditionally hard to reach participants: Lessons learned from three childhood obesity studies.

Authors:  Joanna Buscemi; Lara Blumstein; Angela Kong; Melinda R Stolley; Linda Schiffer; Angela Odoms-Young; Cheryl Bittner; Marian L Fitzgibbon
Journal:  Contemp Clin Trials       Date:  2015-04-03       Impact factor: 2.226

3.  Recruiting and retaining low-income, multi-ethnic women into randomized controlled trials: successful strategies and staffing.

Authors:  Josephine Barnett; Stephanie Aguilar; Mindy Brittner; Karen Bonuck
Journal:  Contemp Clin Trials       Date:  2012-06-23       Impact factor: 2.226

4.  Barriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients With Cancer.

Authors:  Lauren M Hamel; Louis A Penner; Terrance L Albrecht; Elisabeth Heath; Clement K Gwede; Susan Eggly
Journal:  Cancer Control       Date:  2016-10       Impact factor: 3.302

5.  Evidence of Racial Disparities in the Lung Cancer Screening Process: a Systematic Review and Meta-Analysis.

Authors:  Yukiko Kunitomo; Brett Bade; Craig G Gunderson; Kathleen M Akgün; Alexandria Brackett; Lynn Tanoue; Lori A Bastian
Journal:  J Gen Intern Med       Date:  2022-07-15       Impact factor: 6.473

6.  Recruiting low income and racially/ethnically diverse adolescents for focus groups.

Authors:  Melanie Sberna Hinojosa; Hajar Kadivar; Daniel Fernandez-Baca; TaJuana Chisholm; Lindsay A Thompson; Jevetta Stanford; Elizabeth Shenkman
Journal:  Matern Child Health J       Date:  2014-10

7.  Effort required in eligibility screening for clinical trials.

Authors:  Lynne T Penberthy; Bassam A Dahman; Valentina I Petkov; Jonathan P DeShazo
Journal:  J Oncol Pract       Date:  2012-09-11       Impact factor: 3.840

8.  Low-dose computed tomography lung cancer screening as a teachable moment for smoking cessation among African American smokers: A feasibility study.

Authors:  Jamilia R Sly; Sarah J Miller; Yaqi Li; Kemi Bolutayo; Lina Jandorf
Journal:  J Psychosoc Oncol       Date:  2018-09-25

9.  The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations.

Authors:  Andrea M Denicoff; Worta McCaskill-Stevens; Stephen S Grubbs; Suanna S Bruinooge; Robert L Comis; Peggy Devine; David M Dilts; Michelle E Duff; Jean G Ford; Steven Joffe; Lidia Schapira; Kevin P Weinfurt; Margo Michaels; Derek Raghavan; Ellen S Richmond; Robin Zon; Terrance L Albrecht; Michael A Bookman; Afshin Dowlati; Rebecca A Enos; Mona N Fouad; Marjorie Good; William J Hicks; Patrick J Loehrer; Alan P Lyss; Steven N Wolff; Debra M Wujcik; Neal J Meropol
Journal:  J Oncol Pract       Date:  2013-10-15       Impact factor: 3.840

10.  How do social factors explain outcomes in non-small-cell lung cancer among Hispanics in California? Explaining the Hispanic paradox.

Authors:  Manali I Patel; Clayton W Schupp; Scarlett L Gomez; Ellen T Chang; Heather A Wakelee
Journal:  J Clin Oncol       Date:  2013-08-19       Impact factor: 50.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.